These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 23177536)

  • 1. Seizure control by ketogenic diet-associated medium chain fatty acids.
    Chang P; Terbach N; Plant N; Chen PE; Walker MC; Williams RS
    Neuropharmacology; 2013 Jun; 69():105-14. PubMed ID: 23177536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seizure control by derivatives of medium chain fatty acids associated with the ketogenic diet show novel branching-point structure for enhanced potency.
    Chang P; Zuckermann AM; Williams S; Close AJ; Cano-Jaimez M; McEvoy JP; Spencer J; Walker MC; Williams RS
    J Pharmacol Exp Ther; 2015 Jan; 352(1):43-52. PubMed ID: 25326131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant profile of caprylic acid, a main constituent of the medium-chain triglyceride (MCT) ketogenic diet, in mice.
    Wlaź P; Socała K; Nieoczym D; Łuszczki JJ; Zarnowska I; Zarnowski T; Czuczwar SJ; Gasior M
    Neuropharmacology; 2012 Mar; 62(4):1882-9. PubMed ID: 22210332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New experimental therapies for status epilepticus in preclinical development.
    Walker MC; Williams RS
    Epilepsy Behav; 2015 Aug; 49():290-3. PubMed ID: 26189787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats.
    Brandt C; Gastens AM; Sun Mz; Hausknecht M; Löscher W
    Neuropharmacology; 2006 Sep; 51(4):789-804. PubMed ID: 16806297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats.
    Lusardi TA; Akula KK; Coffman SQ; Ruskin DN; Masino SA; Boison D
    Neuropharmacology; 2015 Dec; 99():500-9. PubMed ID: 26256422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the anticonvulsant efficacies and neurotoxic effects of valproic acid, phenytoin, and the ketogenic diet.
    Bough KJ; Eagles DA
    Epilepsia; 2001 Oct; 42(10):1345-53. PubMed ID: 11737171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the interaction between fatty acids and tryptophan responsible for the efficacy of a ketogenic diet in epilepsy? The new hypothesis of action.
    Maciejak P; Szyndler J; Turzyńska D; Sobolewska A; Kołosowska K; Krząścik P; Płaźnik A
    Neuroscience; 2016 Jan; 313():130-48. PubMed ID: 26601775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
    van Vliet EA; Edelbroek PM; Gorter JA
    Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders.
    Augustin K; Khabbush A; Williams S; Eaton S; Orford M; Cross JH; Heales SJR; Walker MC; Williams RSB
    Lancet Neurol; 2018 Jan; 17(1):84-93. PubMed ID: 29263011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiseizure Effects of Ketogenic Diet on Seizures Induced with Pentylenetetrazole, 4-Aminopyridine and Strychnine in Wistar Rats.
    Sanya EO; Soladoye AO; Desalu OO; Kolo PM; Olatunji LA; Olarinoye JK
    Niger J Physiol Sci; 2017 Mar; 31(2):115-119. PubMed ID: 28262846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute anticonvulsant effects of capric acid in seizure tests in mice.
    Wlaź P; Socała K; Nieoczym D; Żarnowski T; Żarnowska I; Czuczwar SJ; Gasior M
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():110-6. PubMed ID: 25445478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised trial of a medium-chain TAG diet as treatment for dogs with idiopathic epilepsy.
    Law TH; Davies ES; Pan Y; Zanghi B; Want E; Volk HA
    Br J Nutr; 2015 Nov; 114(9):1438-47. PubMed ID: 26337751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in antiepileptic efficacy during prolonged treatment with valproic acid: role of inhibition of histone deacetylases?
    Hoffmann K; Czapp M; Löscher W
    Epilepsy Res; 2008 Oct; 81(2-3):107-13. PubMed ID: 18538545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic perturbations associated with the consumption of a ketogenic medium-chain TAG diet in dogs with idiopathic epilepsy.
    Law TH; Volk HA; Pan Y; Zanghi B; Want EJ
    Br J Nutr; 2018 Sep; 120(5):484-490. PubMed ID: 30001753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizure-induced reduction in PIP3 levels contributes to seizure-activity and is rescued by valproic acid.
    Chang P; Walker MC; Williams RS
    Neurobiol Dis; 2014 Feb; 62():296-306. PubMed ID: 24148856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of tiagabine with valproate in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis for non-parallel dose-response relationship curves.
    Luszczki JJ; Krzyzanowski M; Swiader MJ
    Adv Med Sci; 2009; 54(1):75-81. PubMed ID: 19366650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medium-chain triglyceride ketogenic diet is effective for treatment of an adult with super-refractory status epilepticus: a case report and literature review.
    Prasoppokakorn T; Jirasakuldej S; Lakananurak N
    Eur J Clin Nutr; 2019 Dec; 73(12):1594-1597. PubMed ID: 31316173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketogenic diet prevents neuronal firing increase within the substantia nigra during pentylenetetrazole-induced seizure in rats.
    Viggiano A; Stoddard M; Pisano S; Operto FF; Iovane V; Monda M; Coppola G
    Brain Res Bull; 2016 Jul; 125():168-72. PubMed ID: 27381979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats.
    Langer M; Brandt C; Zellinger C; Löscher W
    Neuropharmacology; 2011; 61(5-6):1033-47. PubMed ID: 21736883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.